A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation

Published:2020 Issue:41 Volume:49 Page:14520-14527
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Barresi Elisabetta¹²³⁴^ORCID,Tolbatov Iogann⁵⁶⁷⁴^ORCID,Pratesi Alessandro⁸²⁹⁴^ORCID,Notarstefano Valentina¹⁰¹¹¹²¹³⁴^ORCID,Baglini Emma¹²³⁴^ORCID,Daniele Simona¹²³⁴¹⁴,Taliani Sabrina¹²³⁴¹⁴^ORCID,Re Nazzareno⁵⁶⁷⁴,Giorgini Elisabetta¹⁰¹¹¹²¹³⁴^ORCID,Martini Claudia¹²³⁴¹⁴^ORCID,Da Settimo Federico¹²³⁴¹⁴^ORCID,Marzo Tiziano¹²³⁴¹⁴^ORCID,La Mendola Diego¹²³⁴^ORCID

Affiliation:

1. Department of Pharmacy

2. University of Pisa

3. Pisa

4. Italy

5. Dipartimento di Farmacia

6. Università degli Studi “G. D'Annunzio” Chieti-Pescara

7. I-66100 Chieti

8. Department of Chemistry and Industrial Chemistry

9. 56124 Pisa

10. Department of Life and Environmental Sciences

11. DiSVA

12. Università Politecnica delle Marche

13. Ancona

14. CISUP-Centro per l'Integrazione della Strumentazione Scientifica dell'Università di Pisa

Abstract

The lack of reactivity of the mixed-valence diruthenium(ii,iii) complex [Ru₂(EB106)₄Cl] is due to the properties of its coordinating ligand.

Funder

Università di Pisa

Associazione Italiana per la Ricerca sul Cancro

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/DT/D0DT02527E

Reference57 articles.

1. The resurgence of platinum-based cancer chemotherapy

2. Cellular processing of platinum anticancer drugs

3. Cisplatin: an old drug with a newfound efficacy – from mechanisms of action to cytotoxicity

4. Direct Cellular Responses to Platinum-Induced DNA Damage

5. Targeting platinum anti-tumour drugs: Overview of strategies employed to reduce systemic toxicity

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dimolybdenum (II,II) paddlewheel complexes bearing non-steroidal anti-inflammatory drug ligands: Insights into the chemico-physical profile and first biological assessment;Journal of Inorganic Biochemistry;2024-11

2. Cytotoxic auranofin analogues bearing phosphine, arsine and stibine ligands: A study on the possible role of the ligand on the biological activity;Journal of Inorganic Biochemistry;2024-02

3. Tyrosine kinase inhibitors (TKIs) for ovarian cancer treatment: from organic to inorganic chemotherapeutics towards selectivity—a perspective overview;BioMetals;2023-11-06

4. Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry;Pharmaceuticals;2023-07-12

5. Mechanistic Evaluations of the Effects of Auranofin Triethylphosphine Replacement with a Trimethylphosphite Moiety;Inorganic Chemistry;2023-06-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3